Brain CSPGs inhibited the neurite elongation irreversibly in a dose-dependent manner; complete inhibition was observed at a concentration of 50 nmol uranic acid/ ml. Closely similar dose-dependent inhibition was observed in the forskolin-induced neurite outgrowth from PC1 2D cells. NGF-induced neurite outgrowth from conventional PC1 2 cells was also inhibited completely by 50 nmol uranic acid/ml CSPGs. Some brain CSPGs seemed to be inhibitory, but the cartilage-unique CSPG did not show any inhibitory effect. Chondroitin sulfate, a polysaccharide moiety of CSPGs, did not show any inhibitory effect even at a concentration of 250 nmol uranic acid/ml, while core proteins prepared from brain CSPGs by digestion with chondroitinase ABC exhibited inhibitory activity similar to that of intact CSPGs. This indicates that the site of the inhibitory activity exists in the core protein moiety of brain CSPGs. From these observations, it is conceivable that brain CSPGs are involved in the regulation of neuronal differentiation.
Chondroitin sulfate (CS) and heparan sulfate are the major sulfated glycosaminoglycans (GAGS) in the brain, and CS is predominant in the postnatal rat brain (Oohira et al., 1986) . Biochemical studies have shown that there are several CS proteoglycans (CSPGs) with structurally different core proteins in the rat brain (Normand et al., 1988; Oohira et al., 1988; Gowda et al., 1989) . Some of these CSPGs can be easily solubilized with a physiological salt solution, and others are associated with cellular membranes prepared from the brain (Herndon and Lander, 1990) . Immunohistological studies demonstrated that CSPGs were localized extracellularly in the developing rat brain (Aquino et al., 1984) . Although it has been suggested that neural CSPGs function as modulators of cell adhesion and of migration (for review, see Margolis and Mar-golis, 1989 ) their roles in the development of nervous systems are still poorly understood.
Neuritic growth from immature neurons is an important developmental step in the nervous systems. Several components of the extracellular matrix, including fibronectin, laminin, and some types of collagen, have been shown to promote neurite elongation of neuronal cells in vitro (Akers et al., 1981; Baron von Evercooren et al., 1982; Carbonetto et al., 1983; Davis et al., 1985; Lander et al., 1985) . The effects of proteoglycans and their glycosaminoglycan chains on neuritic growth have also been investigated. Although a basement membrane-type heparan sulfate proteoglycan has been reported to have the neuritepromoting activity by itself (Hantez-Ambroise et al., 1987) it is generally considered that CSPGs do not affect neuritic growth significantly by themselves. However, proteoglycans prepared from the brain have never been used in this kind of experiment. Because brain CSPGs may be different in structure from those of other sources, it is of interest to examine the effect of brain proteoglycans on neuritic growth.
PC12 pheochromocytoma cells begin to extend neurites in response to NGF (Greene and Tischler, 1976) so that the culture system of this cell line has often been used as an experimental model system to study the mechanisms operative in neuritic growth. PC1 2D cells, a flat-shaped variant of PC1 2 cells, are characteristic of the rapid response to NGF in neurite outgrowth (Katoh-Semba et al., 1987) . In the present work, CSPGs, solubilized by PBS from IO-d-old rat brain, were added to the culture medium of PC12D cells in the presence of NGF to examine the effects on NGF-induced neurite outgrowth from the cells.
Materials and Methods
Preparation of CSPGs. CSPGs were solubilized with ice-cold PBS in the presence of protease inhibitors from the brains of 1 O-d-old SpragueDawley rats and were partially purified by stepwise elution from a DEAESephacel column and then by gel filtration on a Sepharose CL-4B column as described previously (Oohira et al., 1988) . To prepare %-sulfatelabeled CSPGs, rats were injected intracerebrally with 740 kBq/rat of carrier-free Na,-YS-0, dissolved in 10 ~1 PBS 24 hr prior to extraction of brain CSPGs. CSPGs were eluted broadly from Sepharose CL-4B in the area, with KaV ranging from 0.1 to 0.6 (see Oohira et al., 1988, their Fig. 1 ). The whole peak was pooled and subjected to ultracentrifugation on a CsCl density gradient under dissociative conditions. CSPGs were recovered almost quantitatively in the bottom fraction, with a density of over 1.38 am/ml. The bottom fraction contained at least 5 different CSPG mole&es, the core proteins of which have molecular weights of 250. 220. 150. 130. and 93 kDa (Oohira et al.. 1988 ). This fraction is hereinafter refkrred' to as CSPG-mixture. ' The brain CSPG with the 250-kDa core protein (designated CSPG-250) was purified from the faster fraction (K,", 0.15-0.32) of the broad peak eluted from Sepharose CL-4B as follows: This fraction was chro-matographed on a column (1.4 x 75 cm) of Sepharose CL-6B at 4°C in 1 M guanidine HCI and 50 mM Tris-HCl (pH, 7.5) containing 2 mM EDTA, 1 mM N-ethylmaleimide, and 0.2 mM phenylmethylsulfonyl fluoride at a flow rate of 7 mbhr. A fraction with Kav ranging from 0.12 to 0.25 was pooled and ultracentrifuged on a CsCl density gradient. The bottom fraction (> 1.45 gm/ml) contained only CSPG-250.
A small CSPG mixture, which did not contain either CSPG-250 or the CSPG with the 220-kDa core protein (CSPG-220), was prepared from the most retarded fraction (K,,, 0.45-0.60) of the broad peak eluted from Sepharose CL-4B. This fraction contained 3 major CSPGs (CSPGs with core proteins of M,s 150, 130, and 93 kDa) and a minor CSPG with the 220-kDa core protein. To remove CSPG-220, the pooled fraction was chromatographed on the Sepharose CL-6B column as described above. A peak fraction with K," ranging from 0.35 to 0.50 was pooled and subjected to ultracentrifugation on a CsCl density gradient as described above. The bottom fraction (> 1.38 gm/ml) consisted mostly of CSPGs with 150-, 130-, and 93-kDa core proteins and no longer contained CSPG-220. This fraction is hereinafter referred to as small CSPGs.
The cartilage-unique CSPG, termed PG-H, was extracted from epiphyseal cartilages of neonatal rats and purified by a method described previously (Matsui et al., 1989) .
All proteoglycan preparations were dialyzed against PBS containing 1 mM sodium azide at 4°C and stored at -80°C. The amount of hexuronate in the proteoglycan solutions was measured by the method of Bitter and Muir (1962) after precipitation of proteoglycans from aliquots of the dialysates with 70% ethanol containing 1% potassium acetate. Protein was determined using the Bio-Rad protein assay (BioRad, Richmond, CA).
Before addition of CSPGs to culture media, CSPGs were precipitated from PBS with ethanol-potassium acetate solution as described above. Precipitates were washed once with 70% ethanol containing 1% potassium acetate. then lvoohilized under sterile conditions. Dried CSPGs were dissolved in the culture medium at a concentration of 1.0 pmol uranic acid/ml (the concentrations of core proteins were 164 &ml for CSPG-mixture, 87.8 &ml for CSPG-250, and 202 &ml for small CSPGs).
Preparation of chondroitin sulfatepolysaccharide. Chondroitin sulfate (CS), the GAG moiety of CSPGs, was prepared from CSPG-mixture as follows: CSPG-mixture was treated sequentially with pronase, 0.2N NaOH, and 5% trichloroacetic acid to release CS from core proteins (Oohira et al., 1986) . Crude CS (5 rmol uranic acid) was dissolved in 5 ml of 2 M urea, 15 mM NaCl, and 50 mM Tris-HCl (pH, 7.5) at room temperature and applied to a column (0.7 x 11 cm) of DEAE-Sephacel equilibrated with the same buffer. CS was eluted with a 15 mM to 0.7 M NaCl aradient in the urea buffer (total, 100 ml) at a flow rate of 10 ml/hr. CS-rich fractions were pooled; and CS was precipitated by adding 3 vol of 95% ethanol containing 1.3% potassium acetate at 0°C. The CS preparation was further purified by gel filtration on a Sepharose CL-6B column (1.4 x 75 cm) in 1 M guanidine HCl and 50 mM Tris-HCI (pH, 7.5) at a flow rate of 7 ml/hr. CS, eluted from the column as a symmetrical peak with a K." of 0.67, was dialyzed against PBS containing 1 mM sodium azide at 4°C.
In addition to the CS preparation from brain CSPGs, we used the following commercial preparations of GAGS in this work: chondroitin sulfate A (composed mainly of chondroitin 4-sulfate units) from whale cartilage, chondroitin sulfate C (composed mainly ofchondroitin 6-sulfate units)from shark cartilage, dermatan sulfate from pig skin, heparan sulfate from bovine kidnev. and hyaluronic acid from human umbilical cords (Seikagaku Kogyo, Tokyo). _ Preparation of CSPG core proteins. CSPGs (1 pmol uranic acid) were digested with 0.2 U protease-free chondroitinase ABC (Seikagaku Kogyo, Tokyo) at 37°C for 1 hr in 1 ml 0.1 M Tris-HCl @H, 7.5) containing 20 PLg bovine serum albumin, 30 mM sodium acetate, 2 mM EDTA, 1 rnt+r N-ethylmaleimide, 0.2 mM phenylmethylsulfonyl fluoride, and 0.07 mM pepstatin. The enzyme reaction was stopped by adding 3 ml of 95% ethanol containing 1.3% potassium acetate at 0°C. After 1 hr at OYZ, the mixture was centrifuged to collect pelleted core proteins. The pellet was washed once with 70% ethanol and 1% potassium acetate at 4"c, then lyophilized under sterile conditions. Before use, core protein preparations were dissolved in culture media at a concentration equivalent to 1 .O pmol uranic acid of intact CSPGs per ml.
In every experiment, an aliquot (5 ~1) of the enzyme reaction mixture was subjected to SDS-PAGE under reducing conditions with dithiothreitol using a 3% stacking gel with a 6% separating gel to confirm the production of core proteins by digestion with chondroitinase ABC. , and small CSPGs (C). Lane 1, intact proteoglycan(s) before enzyme digestion; lane 2, core protein(s) prepared from the corresponding proteoglycan preparations by digestion with protease-free chondroitinase ABC. Enzvme reaction mixture without proteoglycan substrate was also analyzed (C, lane 3). Only bovine serum albumin (B&t), which had been added to the enzyme preparation as a stabilizer, was stained with Coomassie blue.
CeZI culture. PC 12D cells were grown on loo-mm tissue culture dishes in Dulbecco's modified Eagle's medium (DMEM; Gibco 430-2 100) contaming 44.4 mM sodium bicarbonate, supplemented with 5% fetal bovine serum (FBS) and 5 pg/ml insulin. Cells were harvested at mid-Ioa phase in the same medium and reseeded on 96-well plastic tissue culture plates, precoated with 0.1 mg/ml polylysine, at a density of 4.0 x 10) cells/well (or 1.3 x 1 O4 cells/cm*) unless otherwise indicated. After 24 hr of reseeding, the medium (100 pi/well) was replaced with fresh medium containing 5 biological units/ml of 7s NGF prepared by the method of Varon et al. (1972) and CSPGs at various concentrations up to 100 nmol uranic acid/ml (or GAGS up to 250 nmol uranic acid/ml). After 48 hr in culture (total 72 hr), cells were fixed with 2% glutaraldehyde in PBS for 2 hr at room temperature. Cells with processes equivalent in length to 2 or more diameters of the cell body were counted as neurite-bearing cells under a phase-contrast microscope.
Conventional PC1 2 cells were cultured under the same conditions as PC1 2 D cells, except for the substitution of 10% horse serum for insulin. The culture medium was changed every 2 d. On day 9 of cultivation, cells were fixed as described above.
Viability of PC 12D cells attached to the culture dishes was measured by the trypan blue exclusion test as follows: After cultivation, the medium was removed, and the cell layer was washed once with PBS at room temperature, prior to the addition of ttypan blue (0.04% in PBS). After 10 min at room temperature, excess trypan blue was removed. The number of nonviable cells that absorbed trypan blue was counted under a light microscope.
Results

Characterization of brain CSPGs
Three proteoglycan preparations (CSPG-mixture, CSPG-250, and small CSPGs) were analyzed by SDS-PAGE before and after digestion with protease-free chondroitinase ABC (Fig. 1) . When the intact CSPG-mixture was electrophoresed, most of it diffusely remained at the top portion of the separating gel. No other protein bands were detected in this preparation (Fig. 14  lane 1) . Digestion of CSPG-mixture with chondroitinase ABC produced several protein bands (Fig. 14 lane 2) . The molecular weights of the major core proteins have been estimated to be 250, 220, 150, 130, and 93 kDa (Oohira et al., 1988) . Intact CSPG-250 was recovered at the interphase between the stacking Figure 2 . Photomicrographs of PCl2D cells cultured for 48 hr with NGF (A), with NGF and 50 nmol uranic acid/ml of CSPG-mixture (I?). and with NGF and core protein preparation from CSPG-mixture at concentration equivalent to 50 nmol uranic acid/ml (CT'). Scale bar, 100 pm. and the separating gels, while CSPG-250 digested with chondroitinase ABC was observed as a single protein band with an M, of 250 kDa (Fig. 1B) . Digestion of small CSPGs with chondroitinase ABC converted the very diffuse smear at 200-250 kDa (Fig. lC', lane 1) into relatively sharp protein bands (Fig.  lC, lane 2) . The major bands had molecular weights of 150, 130, and 93 kDa, and in this proteoglycan preparation, neither CSPG-250 nor CSPG-220 was detected.
NGF-induced neurite outgrowth of PC12 and PC12D cells Conventional PC12 cells begin to extend their neurites after a lag period of a few days in response to NGF (Greene and Tischler, 1976 ) whereas PC1 2D cells immediately elongate their neurites (Katoh-Semba et al., 1987) . Under culture conditions used here, the percentage of neurite-bearing PC12D cells reached a plateau after 48 hr, when about 70% of cells extended neurites ( Fig. 2A; see also Fig. 4) . In contrast, in the culture of conventional PC12 cells, it took more than 1 week, with a change of medium every 2 d, for the percentage of neurite-bearing cells to reach a maximum level.
In the preliminary experiments, both conventional PC1 2 cells and PC 12D cells were cultured in medium containing CSPGmixture at a concentration of 50 or 100 nmol uranic acid/ml in the presence of NGF. We found that either concentration of CSPG-mixture completely inhibited NGF-induced neurite outgrowth, not only from conventional PC12 cells, but also from PC1 2D cells (Fig. 2B) . Therefore, to take advantage of the shortterm culture, we used mainly PC 12D cells in the present work.
Dose-dependent inhibition of neurite outgrowth To examine whether the inhibition by brain CSPGs of NGFinduced neurite outgrowth from PC 12D cells occurred in a dosedependent manner, CSPG-mixture was added to the culture medium at various concentrations. No inhibition was observed at concentrations less than 1 nmol uranic acid/ml (Fig. 3) . The inhibitory effect became detectable around 1.5 nmol/ml and increased almost linearly with increasing concentration of CSPGmixture up to 15 nmol/ml. Complete inhibition was observed at a concentration of 50 nmol uranic acid/ml. At this concentration, PC12D cells were rounded and formed cell aggregates (Fig. 2B) . Viability of cells cultured in the presence of both NGF and CSPG-mixture was 89.4 f 3.00/o (mean + SD), which was virtually identical to that (90.4 f 3.7%) of cells cultured in the presence of NGF alone.
To examine which CSPG(s) in CSPG-mixture was responsible for the observed inhibitory effects, either CSPG-250 or small CSPGs was added to the culture medium with NGF. Both CSPG-250 and small CSPGs inhibited NGF-induced neurite outgrowth from PC1 2D cells in a dose-dependent manner similar to that of CSPG-mixture (Fig. 3) . This finding indicates that some CSPG species, including CSPG-250, have the inhibitory activity.
PC1 2D cells extend neurites in response to CAMP-enhancing reagents, such as forskolin (10 PM) in the culture medium, with a mechanism different from that operative in NGF-induced neurite outgrowth (Katoh-Semba et al., 1987) . Therefore, it was of interest to examine whether or not brain CSPGs would inhibit forskolin-induced neurite outgrowth from PC 12D cells. Brain CSPGs inhibited the neurite elongation induced by forskolin in a dose-dependent manner closely similar to that for inhibition of NGF-induced neurite outgrowth (data not shown, but see Table 1 ).
Efects of proteoglycan core proteins A proteoglycan has 2 structurally different domains, a core protein moiety and a GAG moiety. The GAG moiety of brain CSPGs is a CS polysaccharide composed mainly of chondroitin 4-sulfate units (Oohira et al., 1988) . To examine whether or not CS polysaccharide has an inhibitory effect on neurite outgrowth, we carried out 2 different series of experiments. First, the car- tilage-unique CSPG, or PG-H, prepared from rat hyaline cartilage was added to the culture medium of PC 12D cells, instead of brain CSPGs. Rat PG-H bears CS side chains abundant in chondroitin 4-sulfate units (Oohira and Nogami, 1980) . The addition of rat PG-H did not cause inhibition of NGF-induced neurite outgrowth from PC 12D cells even at a concentration of 100 nmol uranic acid/ml (Fig. 3) . Second, various GAGS, the polysaccharide moieties of proteoglycans, were added to the culture medium. CS polysaccharide prepared from CSPG-mixture had no effect on NGF-induced neurite outgrowth at a concentration of 50 nmol uranic acid/ml. In addition, various commercial preparations of GAGS, such as chondroitin sulfate A, chondroitin sulfate C, dermatan sulfate, heparan sulfate, and hyaluronate, did not show any inhibitory effect even at a concentration of 250 nmol uranic acid/ml. These observations imply that the site of inhibitory activity exists in a domain other than in the CS polysaccharide, namely, in the core protein moiety of CSPGs.
Core proteins prepared from CSPG-mixture, from CSPG-250, or from small CSPGs were added separately to the culture medium of PC12D cells at various concentrations. All these preparations inhibited NGF-induced neurite outgrowth from PC 12D cells in a dose-dependent manner. The morphology of cells in the presence of core proteins was almost identical to that in the presence of the corresponding intact CSPGs (Fig. 2C for PC 12D cells cultured with core proteins from CSPG-mixture at a concentration equivalent to 50 nmol uranic acid/ml). Table  1 summarizes the dose at which the neurite outgrowth from PC1 2D cells is inhibited by 50% of the maximum level (ID,,) of intact CSPGs and their core proteins. The ID,, of a core protein preparation was always higher (1.2-2.0-fold) than that of the corresponding proteoglycan preparation. This finding suggests that the primary inhibition site exists in the core protein moiety of brain CSPGs, but that an integral proteoglycan structure may be necessary for the full expression of inhibitory activity. Efects of CSPGs on neurite-elongating cells In all the experiments described above, CSPGs were added to the culture medium with NGF at the same time. Therefore, we treated cells with CSPGs during elongation and when neurites were already fully elongated. As shown in Figure 4 , the percentage of neurite-bearing PC12D cells was 40-50% of total population after 15 hr of cultivation in the presence of NGF. At this time, medium was replaced with fresh medium containing both NGF and CSPGs (50 nmol uranic acid/ml), and the culture was continued for a further 48 hr. The percentage of neurite-bearing cells did not increase in the presence of CSPG-250 and tended to decrease slightly in the presence of CSPGmixture and small CSPGs (Fig. 4) . This finding showed that brain CSPGs stop neurite elongation when they are added to the culture. When PC 12D cells were cultured with NGF for 48 hr, the proportion of net&e-bearing cells to the total population reached a plateau (Fig. 4) . Brain CSPGs (50 nmol uranic acid/ ml) were added to this culture, and the culture was continued for another 48 hr. The percentage of neurite-bearing cells decreased by about 20% in the case of CSPG-250 and by 30% in those of small CSPGs and CSPG-mixture (Fig. 4) , suggesting that brain CSPGs retract some neurites from PC12D cells.
Adsorption of CSPGs to culture
We examined the reversibility of neurite outgrowth inhibition by brain CSPGs. PC1 2D cells pretreated with NGF and CSPGs (50 nmol uranic acid/ml) for 48 hr were cultured for a further 24 hr in fresh medium with NGF and without CSPGs. The percentage of neurite-bearing cells did not increase significantly. This indicates that the inhibition by brain CSPGs of neurite outgrowth from PC12D cells is irreversible, at least for the first 24 hr after replacement of the medium. It is likely that brain CSPGs are adsorbed to the culture dishes and/or cells, and that the CSPGs attached to the culture cannot be washed out easily.
To estimate the amount of brain CSPGs adsorbed to the culture, ?S-labeled CSPG-mixture (specific radioactivity, 400 dpm/nmol uranic acid) was added to the culture medium at a concentration of 50 nmol uranic acid/ml (or 20,000 dpm/ml). As a control, YS-labeled CS polysaccharide with the same specific radioactivity was used. The amount of CS polysaccharide attached to the culture was 0.60 nmol uranic acid/60-mm dish, (Table 2 ). In contrast, over 3 times as many intact CSPGs as CS polysaccharides attached to the culture dish. PC12D cells adhering to the culture dish resulted in a further increase in the amount of attached CSPGs (Table 2 ). This increase could be attributed mainly to binding of CSPGs to PC 12D cells.
Discussion
In the developing rat brain, CSPGs have been solubilized effectively with a physiological salt solution and are localized mainly in the intercellular space (Aquino et al., 1984) . Therefore, addition of these soluble CSPGs to the culture medium ofneural cells is a practical way to elucidate their roles in the behavior of neural cells. We have demonstrated that brain CSPGs solubilized with PBS inhibit both NGF-induced and forskolin-induced neurite outgrowth from PC 12D cells when added to culture medium. The primary site of the inhibitory activity was also shown to exist in the core protein moiety of the soluble CSPGs of the brain.
Our present experiments address the role of CSPGs present in the soluble fraction from IO-d-old rat brain. The insoluble or particulate fraction contains a distinct set of proteoglycans, and the composition of proteoglycans both in the soluble and in the particulate fraction changes with age (Herndon and Lander, 1990) . Therefore, it is plausible that both soluble CSPGs of the brain at other developmental stages and membrane-associated proteoglycans play roles other than the inhibition of neurite outgrowth.
In fact, a membrane-associated CSPG (Cat-30 1 antigen) expressed in the brain at a relatively late developmental stage has been implicated in the maturation of functional connections between neurons (Zaremba et al., 1989) . The cultures were carried out in 60-mm culture dishes with 5 ml of medium. 'ISlabeled CS or CSPG-mixture (specific radioactivity, 400 dpm/nmol uranic acid), instead of unlabeled CS or CSPGs, was added to the culture medium. After 48 hr of cultivation, the medium was removed, and the cell layer was washed with I ml of PBS 3 times. Cells and materials attached to the dish were solubilized completely with 2% SDS and 50 rnM Tris-HCI (pH, 7.5) by the method described previously (Oohira et al., 1982) . An aliquot of the SDS solution was mixed with Aquasol-(New England Nuclear, Boston, MA), and the 'S-radioactivity was measured. Control experiments were performed using 60-mm dishes without cells. y The values in the parentheses represent the percentage of the amount of CS adsorbed on a 60-mm dish without cells.
Heparan sulfate proteoglycans from several sources promote neurite outgrowth either by themselves or through a functional complex with laminin Matthew et al., 1985; Hantez-Ambroise et al., 1987; Dow et al., 1988) . On the contrary, CS-rich substrata or CSPGs appear to inhibit neurite outgrowth. For example, Vema et al. (1989) cultured embryonic chick dorsal root ganglia on various GAG-bound collagen substrata and found that the binding of CS, not heparan sulfate, to collagen substrata decreased the ability of collagen to promote neurite elongation from the ganglia. Similar results were also reported by Akeson and Warren (1986) using PC12 cells cultured on GAG-containing artificial substrata. More recently, Muir et al. (1989) demonstrated that a proteoglycan-containing material produced by schwannoma cells could mask the neuritepromoting activity of laminin, and that the inhibitory activity of this material was eliminated by digestion with GAG lyases, including chondroitinase ABC. Furthermore, Snow et al. (1990) have shown that cartilage proteoglycan, which bears both CS and a small amount of keratan sulfate, inhibits the neurite extension from dorsal root ganglion neurons. Selective enzymatic removal of the GAG moieties, leaving only the core protein moiety of the cartilage proteoglycan, resulted in a complete lack of inhibition. All these experiments indicate that the CS moiety of proteoglycans, rather than the core protein moiety, is responsible for the inhibition of neurite outgrowth. However, in our present work, the inhibitory activity of the brain CSPGs on neurite outgrowth was not eliminated by digestion of the CS polysaccharide moiety by protease-free chondroitinase ABC (Table 1) . This is the first report to demonstrate that the core protein moiety of brain CSPGs can inhibit neurite elongation. Although the result shown in Table 2 suggests that the binding of brain CSPGs to PC 12D cells with the core protein moiety is involved, the exact mechanism for the inhibition of neurite elongation from PC12D cells by brain CSPGs remains unknown.
Although Snow et al. (1990) reported that cartilage proteoglycan inhibited neurite elongation from dorsal root ganglion neurons, we were unable to demonstrate this effect on neurite extension from PC12D cells (Fig. 3) . This discrepancy may be due to a difference in cell type. Additionally, the difference in the proteoglycan concentration used may be another cause. Snow et al. (1990) cultured cells on nitrocellulose coated with the proteoglycan solution at a concentration of 1 m&ml, whereas we added it to the culture medium at various concentrations up to 100 nmol uranic acid/ml (about 50 pg proteoglycan/ml), all of which were far lower than theirs.
Brain CSPGs have been shown to contain some glycoproteintype oligosaccharides, in addition to CS polysaccharide chains, covalently bound to the core protein polypeptides (Krusius et al., 1987; Gowda et al., 1989) . Because the core proteins used in this work were prepared by digestion of brain CSPGs with protease-free chondroitinase ABC, the glycoprotein-type oligosaccharides are considered to remain intact on the core protein polypeptides. In the present work, CSPG-250 inhibited the neurite outgrowth in a similar manner to that of small CSPGs (Fig.  3, Table 1 ). It is of interest to consider that CSPG-250 and other brain CSPGs bear a common glycoprotein-type oligosaccharide on their core protein polypeptides that inhibits neurite outgrowth.
Enormous efforts have been made to ascertain the neurotrophic factors that support the survival and/or differentiation of neuronal cells, but little attention has been paid to materials that can suppress the differentiation of neuronal cells. During brain development, a factor could suppress neuritogenesis of neuroblasts until a certain developmental stage. Similarly, in the mature brain, excess sprouting and elongation of neurites from neurons must be suppressed under physiological conditions. Recently, it has been shown that the brain contains some factors that inhibit neurite outgrowth. For example, Caroni and Schwab (1988) isolated 2 membrane protein fractions from rat central myelin that inhibited neurite growth. The M,s of these proteins were estimated to be 250 and 35 kDa. Uchida and Tomonaga (1989) also found an inhibitory factor in aqueous extracts of normal human brains. Interestingly, this factor was not detectable in aqueous extracts of Alzheimer's disease brains. However, these factors seem to be different from soluble brain CSPGs, because the proteins isolated by Caroni and Schwab (1988) are membrane bound and have different physicochemical properties. The soluble factor reported by Uchida and Tomonaga (1989) inhibits both neuronal survival and neurite formation, while the brain CSPGs inhibit only neurite formation. No effect of the brain CSPGs on PC12D cell survival was observed.
